Clicky

Sino Biopharmaceutical ADR(SBHMY)

Description: Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.


Keywords: Natural Sciences Pharmaceutical Products Medication Health Sciences Medical Technology Pharmacology Tumor Hepatitis Tablet Chemical Engineering Management Consultancy Services Health Food Ophthalmic Optometry Analgesic Orthopedic Ophthalmic Products Health Food Products Bip Chemical Medicines Ngg Fructose Respiratory System Zhi Medical Technology Development Orthopedic Diseases Yinishu Yit Chemical Medicine Getai Medical Management Consultancy Services Surgical Procedure Services Tai Suke Tianjie

Home Page: www.sinobiopharm.com

Office Tower
Wan Chai,
Hong Kong
Phone: 852 2802 9886


Officers

Name Title
Ms. Y. Y. Tse Exec. Chairwoman of the Board
Mr. Eric S. Y. Tse CEO & Exec. Director
Mr. Ping Tse Founder & Sr. Vice Chairman
Ms. Cheung Ling Cheng Exec. Vice Chairwoman of the Board
Ms. Mingqin Li VP & Exec. Director
Mr. Zhoushan Tian Exec. Director
Mr. Hsin Tse VP & Exec. Director
Ms. Fai Chia VP & Assistant to the Founding Chairman
Dr. Wei Nong Ye Assistant to Founding Chairman & GM of R&D Department
Ms. Wun Tse Assistant to the Founding Chairman

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 20.8333
Trailing PE: 10.3097
Price-to-Book MRQ: 2.533
Price-to-Sales TTM: 0.4095
IPO Date:
Fiscal Year End: December
Full Time Employees: 25552
Back to stocks